stockrowClover Health Investments, Corp.
CLOV Healthcare Healthcare Plans
Clover Health Investments, Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 40.3% from fiscal 2024.
- Revenue
- +52.9%
- EPS
- +350.0%
- Free cash flow
- +508.9%
Quarter to September 2026, against a year earlier
Follow CLOV
Alert me
Clover Health Investments, Corp. (CLOV) Current ratio
Clover Health Investments, Corp.'s current ratio at the end of the quarter to 30 September 2026 was 1.5×, up 0.1× from fiscal 2025 (1.5×). Over the past ten years it has ranged from 0.0× (fiscal 2019) to 2.0× (fiscal 2021); the current reading is higher than 57% of that period. That is above the Healthcare Plans industry median of 1.3× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.5× | (8.26%) |
| FY2024 | 1.6× | (1.95%) |
| FY2023 | 1.6× | 13.16% |
| FY2022 | 1.4× | (28.28%) |
| FY2021 | 2.0× | 74.77% |
| FY2020 | 1.2× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 1.5× | 3.03% |
| Jun 2026 | 1.5× | 12.79% |
| Mar 2026 | 1.3× | (9.71%) |
| Dec 2025 | 1.5× | (13.82%) |
| 24 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| PGNY Progyny, Inc. compare | 1.9× |
| ALHC Alignment Healthcare, Inc. compare | 1.7× |
| MOH Molina Healthcare, Inc compare | 1.7× |
| HUM Humana Inc. compare | 1.6× |
| CLOV Clover Health Investments, Corp. | 1.5× |
| ELV Elevance Health, Inc. compare | 1.5× |
| CNC Centene Corporation compare | 1.2× |
| CI Cigna Group compare | 0.7× |
| OSCR Oscar Health, Inc. compare | 0.0× |
| Healthcare Plans industry median | 1.3× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on CLOV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement